Dovato: Uses, How It Works, and Common Side Effects

Dovato is a once-a-day oral tablet that may be used to treat HIV-1 infection in certain people 12 years and older who weigh at least 25 kg.

Clinical trials have shown Dovato is very effective at suppressing HIV-1 resulting in undetectable levels of the virus in your blood.

It is a complete treatment option that contains two antivirals: dolutegravir and lamivudine. It was first approved by the FDA in 2019.

Both medications in Dovato work by stopping the virus from multiplying in the body. Dolutegravir is an integrase inhibitor.

It works by blocking an enzyme called integrase, which HIV needs to insert its genetic material into the DNA of healthy cells.

Lamivudine is a nucleoside reverse transcriptase inhibitor, or NRTI.

It interferes with another enzyme the virus needs called reverse transcriptase.

Common side effects of Dovato may include headache, tiredness, nausea, diarrhea, anxiety, sleep problems, and weight gain.

This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.

Always consult with your healthcare provider.